Tag: Riastap

According to the U.S. Food and Drug Administration (FDA) label, the most common adverse reactions reported in clinical trials for RiaSTAP were fever and headache. It is crucial for patients and caregivers to be aware of **what are the side effects of RiaSTAP?** to ensure proper monitoring and management during treatment.

Congenital fibrinogen deficiency is a rare bleeding disorder affecting the body's ability to clot blood, with incidence rates estimated between one in one million and one in two million. **What is RIASTAP?** It is a concentrated human fibrinogen replacement therapy designed to manage and prevent bleeding in patients with this condition.